Hepatitis B Virus (HBV) Infection and Re-activation During Nucleos(t)ide Reverse Transcriptase Inhibitor-Sparing Antiretroviral Therapy in a High-HBV Endemicity Setting (vol 5, ofy251, 2018) by Abdullahi, Adam et al.
C O R R I G E N D UM
Open Forum Infectious Diseases
Hepatitis B Virus (HBV) Infection and Re-activation During 
Nucleos(t)ide Reverse Transcriptase Inhibitor–Sparing 
Antiretroviral Therapy in a High–HBV Endemicity Setting
Adam Abdullahi, Olga Mafotsing Fopoussi, Judith Torimiro, Mark Atkins, Charles Kouanfack, and Anna Maria Geretti
The sentence: “Patients eligible to enter MANET were estab-
lished on 2 NRTIs plus a PI/b for ≥12 months and showed a 
CD4 count >200 cells/mm3 and a plasma HIV-1 RNA load.” 
should read: “Patients eligible to enter MANET were estab-
lished on 2 NRTIs plus a PI/b for ≥12 weeks and showed a CD4 
count >100 cells/mm3 and a plasma HIV-1 RNA load.” This has 
been updated in the original article.
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